The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Equity Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.

Transactions / P•••••• H••••••

I••••• invests in P•••••• H••••••, a premium clinical audiology business

Type not statedannouncedannounced Mar 25, 2026Fact
What happened
Target
P•••••• H••••••
Platform
not an add-on on record
Control
unknown
Share acquired
unknown
Industry
healthcare / clinic
Target location
unknown
Seller kind
unknown
Rollover
unknown
Values, only where disclosed
Enterprise value
Not disclosed
Purchase price
Not disclosed
Equity value
Not disclosed
Target revenue
Not disclosed
Target EBITDA
Not disclosed
Multiple
Not disclosed
Parties and roles
5 named
Buy side
  • A••••• G••••Board appointeeconfirmed
    “In addition to Jonathan, I•••••’s H•••• D•••••••• and A••••• G•••• will join the board alongside Royston G••••, who has advised P•••••• on growth strategy for a number of years.”
  • H•••• D••••••••Deal partnerconfirmed
    “H•••• D••••••••, Partner at I•••••, commented:”
  • I•••••Sponsorconfirmed
    “I••••• invests in P•••••• H••••••, a premium clinical audiology business | published on I•••••'s own news page www.imbiba.com”
Side not stated
Evidence
“I••••• invests in P•••••• H••••••, a premium clinical audiology business”
Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)confidence 80%recorded Sep 18, 2026
I••••• invests in P•••••• H••••••, a premium clinical audiology business | Private Equity Intelligence | DFX